Australia Oligonucleotide Synthesis Market to 2032

Overview

The Australia Oligonucleotide Synthesis Market is expected to reach a 137.05 USD Billion by 2032 and is projected to grow at a CAGR of 18.39% from 2025 to 2032.

Revenue, 2024 (USD Billion)
65.33
Forecast, 2032 (USD Billion)
137.05
CAGR, 2024 - 2032
18.39%
Report Coverage
Australia

Australia Oligonucleotide Synthesis Market 2018-2032 USD Billion

Australia Oligonucleotide Synthesis Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 65.33 USD Billion
  • Projected Market Size (2032): 137.05 USD Billion
  • CAGR (2025-2032): 18.39%

Key Findings of Australia Oligonucleotide Synthesis Market

  • The Australia Oligonucleotide Synthesis Market was valued at 65.33 USD Billion in 2024.
  • The Australia Oligonucleotide Synthesis Market is likely to grow at a CAGR of 18.39% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment DNA Oligonucleotides in Product Type Segment accounted for the largest share of the market with a revenue of 39.21 USD Billion
  • The fastest growing segment Oligonucleotide-Based Drugs in Type Segment grew Fastest with a CAGR of 20.31% during the forecast period from 2024 to 2032.

Australia Oligonucleotide Synthesis Market Scope

Australia Oligonucleotide Synthesis Market Segmentation & Scope
Service Type
  • Oligo Synthesis
  • Predesigned Oligos
  • Custom Oligos
Application
  • Others
  • Diagnostic Applications
  • Therapeutic Applications
  • Research Applications
End User
  • Others
  • Hospitals
  • Contract Research Organizations
  • Academic & Research Institutes
  • Biopharmaceutical & Biotechnology Companies
Type
  • Array-Based Oligos
  • Linkers & Adaptors
  • Large-Scale Synthesized Oligos
  • Intermediate-Scale Synthesized Oligos
  • Probes
  • Primers
  • Oligonucleotide-Based Drugs
Consumables
  • Others
  • Kits & Reagents
  • Instruments
Product Type
  • RNA Oligonucleotides
  • DNA Oligonucleotides

Australia Oligonucleotide Synthesis Market Data Coverage Insights

Study Period 2024-2032
Base Year 2018
Unit Revenue in USD Billion
Market Value in 2024 65.33 USD Billion
Market Value in 2032 137.05 USD Billion
CAGR (2025-2032) 18.39%
Historic Data 2016-2023
Market Segments Covered Service Type,Application,End User,Type,Consumables ,Product Type

Regional Insights:

  • Leading Market (2024-2032): Australia, leading in terms of revenue 65.33 USD Billion in 2024
    • Key Country: Australia, leading in terms of revenue with value of 65.33 USD Billion in 2024.

Segments and Scope

  • Australia Oligonucleotide Synthesis Market to 2032, By Service Type
    • Custom Oligos is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 30.32 USD Billion in the year 2024.
    • Custom Oligos is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 19.78 % in forecast period 2025-2032.
  • Australia Oligonucleotide Synthesis Market to 2032, By Application
    • Research Applications is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 38.92 USD Billion in the year 2024.
    • Research Applications is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 19.17 % in forecast period 2025-2032.
  • Australia Oligonucleotide Synthesis Market to 2032, By End User
    • Biopharmaceutical & Biotechnology Companies is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 31.00 USD Billion in the year 2024.
    • Contract Research Organizations is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 18.76 % in forecast period 2025-2032.
  • Australia Oligonucleotide Synthesis Market to 2032, By Type
    • Oligonucleotide-Based Drugs is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 26.17 USD Billion in the year 2024.
    • Oligonucleotide-Based Drugs is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 20.31 % in forecast period 2025-2032.
  • Australia Oligonucleotide Synthesis Market to 2032, By Consumables
    • Instruments is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 34.87 USD Billion in the year 2024.
    • Kits & Reagents is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 17.49 % in forecast period 2025-2032.
  • Australia Oligonucleotide Synthesis Market to 2032, By Product Type
    • DNA Oligonucleotides is the largest segment in Australia Oligonucleotide Synthesis Market to 2032 with a revenue of 39.21 USD Billion in the year 2024.
    • DNA Oligonucleotides is the Fastest growing segment in Australia Oligonucleotide Synthesis Market to 2032 with a Growth rate of 19.06 % in forecast period 2025-2032.

Australia Oligonucleotide Synthesis Market Company Share Analysis

 
Australia Oligonucleotide Synthesis Market Company Share Analysis
Australia Oligonucleotide Synthesis Market Company Share Analysis

Australia Oligonucleotide Synthesis Market Geographical Sales Distribution, 2018-2032 USD Billion

Australia Oligonucleotide Synthesis Market Geographical Sales Distribution, 2018-2032 USD Billion

Australia Oligonucleotide Synthesis Market Company Profiling

Australia Oligonucleotide Synthesis Market Company Profiling
Frequently Asked Questions
The Australia Oligonucleotide Synthesis Market is segmented based on Segmentation Service Type,Application,End User,Type,Consumables ,Product Type.
Australia Oligonucleotide Synthesis Market was valued at USD 65.33(Revenue in USD Billion) in 2018.
Australia Oligonucleotide Synthesis Market is projected to grow at a CAGR of 18.39% during the forecast period of 2024 to 2032.
The DNA Oligonucleotides segment is expected to dominate the Australia Oligonucleotide Synthesis Market, holding a largest market share of 39.21 USD Billion in 2024

Australia Oligonucleotide Synthesis Market Scope

Australia Oligonucleotide Synthesis Market Segmentation & Scope
Service Type
  • Oligo Synthesis
  • Predesigned Oligos
  • Custom Oligos
Application
  • Others
  • Diagnostic Applications
  • Therapeutic Applications
  • Research Applications
End User
  • Others
  • Hospitals
  • Contract Research Organizations
  • Academic & Research Institutes
  • Biopharmaceutical & Biotechnology Companies
Type
  • Array-Based Oligos
  • Linkers & Adaptors
  • Large-Scale Synthesized Oligos
  • Intermediate-Scale Synthesized Oligos
  • Probes
  • Primers
  • Oligonucleotide-Based Drugs
Consumables
  • Others
  • Kits & Reagents
  • Instruments
Product Type
  • RNA Oligonucleotides
  • DNA Oligonucleotides
Frequently Asked Questions
The Australia Oligonucleotide Synthesis Market is segmented based on Segmentation Service Type,Application,End User,Type,Consumables ,Product Type.
Australia Oligonucleotide Synthesis Market was valued at USD 65.33(Revenue in USD Billion) in 2018.
Australia Oligonucleotide Synthesis Market is projected to grow at a CAGR of 18.39% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Oligonucleotide Synthesis Market for final year is USD 137.05 (USD Billion).

Australia Oligonucleotide Synthesis Market Company Profiling

Australia Oligonucleotide Synthesis Market Company Profiling
Frequently Asked Questions
The Australia Oligonucleotide Synthesis Market is segmented based on Segmentation Service Type,Application,End User,Type,Consumables ,Product Type.
Australia Oligonucleotide Synthesis Market was valued at USD 65.33(Revenue in USD Billion) in 2018.
Australia Oligonucleotide Synthesis Market is projected to grow at a CAGR of 18.39% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Oligonucleotide Synthesis Market for final year is USD 137.05 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.